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Background: Natural products including, traditional medicinal plants have emerged as a tempting alternative to
conventional chemotherapeutic protocols of leukemia because of their minimum side effects and less documented
drug resistance.
Methods: Ethanol extracts were prepared from Thymus vulgaris L. and Origanum syriacum L. plants and
investigated against the THP-1 leukemia cell line and freshly isolated peripheral blood mononuclear cells
(PBMCs). The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay and the lactate dehydrogenase
(LDH) assay were respectively used to determine the cellular viability and cytotoxicity in response to treatment with
increasing extract concentrations.
Results: Both extracts exhibited a concentration dependent reduction in viability of the THP-1 cells (IC50 = 2.126 mg/mL
for O. syriacum, and 0.1569 mg/mL for T. vulgaris). O. syriacum was more potent against the PBMCs (IC50 = 0.4247 mg/mL),
while T. vulgaris was moderately selective (IC50 = 0.3345 mg/mL with PBMCs and SI = 2.1). Only in O. syriacum the reduction
in cells viability was caused by cytotoxic effect against leukemic cells (LC50 = of 9.646 mg/mL).
Conclusion: T. vulgaris and O. syriacum are both antileukemic in vitro. T. vulgaris represents a potential selective cytostatic
and safe target for future anticancer agents’ development. O. syriacum on the other hand is cytotoxic against the leukemia
cell line THP-1.
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Depending on its type, leukemia may be successfully
treated with chemotherapy, radiation therapy, hormonal
therapy, or bone marrow transplantation. However,
chemotherapeutic agents are highly toxic to a wide range
of normal body cells, and thus are associated with diverse
side effects. In addition, multiple drug resistance is a
major determinant of chemotherapy failure. Therefore,
natural products including, traditional medicinal plants,
have emerged as a tempting more tolerated alternative
with minimum side effects.
The leaves of Origanum syriacum L. (Syrian Oregano),
which belongs to the Lamiaceae family and inhabits a
large area in the eastern Mediterranean, have been* Correspondence: d_fariss@yahoo.com
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unless otherwise stated.widely used in the traditional herbal medicine [1,2]. Its
composition and effects as antioxidant and antibacterial
were extensively studied, but few were concerned with
the antiproliferative and anticancer activities of this
plant [3,4].
Thymus vulgaris L. (thyme) is a member of the genus
Thymus (Lamiaceae family) which is predominantly
found in the Mediterranean region, Asia, Southern
Europe and North Africa [5]. Extracts of T. vulgaris are
traditionally used as anti-asthmatic, bronchodilator,
antitussive, antispasmodic [6], antibacterial, and antifungal
[7,8]. In addition, these extracts have shown immunomo-
dulating properties [9,10]. Different studies proposed that
extracts of Thymus vulgaris may have potential anticancer
effects [11-15].
In this study, we investigated the antiproliferative and
cytotoxic effects of extracts from Origanum syriacumtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cell line THP-1 and human peripheral blood mononuclear
cells (PBMCs) isolated from normal controls.Materials
All cell culture reagents, media and supplements as well as
cell viability kits and syringe filters were purchased from
Sigma Aldrich (Israel). The THP-1 cell line was purchased
from the European Collection of Cell Cultures (ECACC,
UK). Cell culture flasks, well plates and other tissue culture
plastics were purchased from Greiner Bio-One (Germany).Methods
Collection of plant materials and preparation of extracts
T. vulgaris seeds were purchased from PlantiCo (Poland)
and implanted for six months. O. syriacum were obtained
from Al-Breem plantation (Khanyounus) and authenticated
by Dr. Mohammad Abo-Oda (PhD plant taxonomy, Alaqsa
University, Gaza). Aerial parts were collected, washed,
air-dried under shade for 3 weeks, and then completely
dried by oven at 40°C for 1 to 1.5 hour.
Both plant extracts were prepared by soaking the dried
and grinded aerial parts in ethanol at room temperature
with occasional mixing (7 days, 40% ethanol for O.
syriacum; and 4 days, 90% ethanol for T. vulgaris) in
a weight/solvent volume ratio of 1/10. Different ethanol
concentrations were used according to the solubility
preferences of the literature detailed effective compounds
of each plant. The extracts were filtered under vacuum for
three times, and dried by rotary evaporator at 40°C for T.
vulgaris and 45°C for O. syriacum.
O. syriacum stock solution was finally prepared at a con-
centration of 200 mg of the dry extract/mL of RPMI-1640
medium with 10% fetal bovine serum (FBS). T. vulgaris
stock solution was prepared at the same concentration in
dimethyl sulfoxide (DMSO). DMSO was used because T.
vulgaris dry extract contains high percentage of oils and
does not dissolve in the aqueous RPMI-1640 medium. The
stock solutions were stored at −20°C until used.Cell line culturing and maintenance
The THP-1 cell line was derived from the peripheral blood
of a 1 year old male with acute monocytic leukemia. The
cells were cultured in modified RPMI-1640 complete
medium with 2.05 mM L-glutamine and 25 mM HEPES,
supplemented with 10% heat inactivated FBS at 37°C in a
humidified atmosphere with 5% CO2. Cell counts and
viability estimation by trypan blue dye exclusion test were
performed regularly. Throughout the study procedures,
THP-1 cells were maintained in a logarithmic growth
phase at a concentration between 105-106 cells/mL. Media
feeding was performed periodically every 2–4 days.Isolation of human Peripheral Blood Mononuclear
Cells (PBMCs)
PBMCs were isolated from sodium heparin anticoagulated
venous blood of healthy donors using Sigma’s Histopaque-
1077 as recommended. The donors’ consents were
obtained before sample collection, and the procedure
was approved by the local Helsinki committee of the
Palestinian Health Research Council, according to the
World Medical Association Declaration of Helsinki
(approval reference No. 1-12/2012). The cells were sus-
pended at a concentration of 106 cells/mL in modified
RPMI-1640 medium, with 2.05 mM L-glutamine and
25 mM HEPES, supplemented with 10% FBS, 5 μg/ mL
phytohemagglutinin (PHA), 100 μg/mL streptomycin, and
100 U/mL penicillin.
Cells preparation and extracts treatment
THP-1 cells in the exponential growth phase and viability
of at least 95% and freshly isolated PBMCs with viability
of at least 98% were used for the viability assays. The cells
were seeded in 96-well plates at a density of 104 THP-1
cells/well and 105 PBMCs cells/well in 100 μL of the
culture medium. Another 100 μL of the proper extract
working concentration were added to the corresponding
wells in triplicates, and the cells were incubated for
48 ± 1 hours in a humidified CO2 incubator at 37°C
and 5% CO2.
The various extract working concentrations were
prepared by dilution of the stock solutions in culture
medium and filter-sterilization with 0.22 μm Millex-GP
syringe filters. Corresponding DMSO concentrations
were similarly prepared as vehicle controls for T. vulgaris
extract.
Cell viability assay
The THP-1 cells and PBMCs previously incubated with
the proper extract or DMSO concentration were washed
several times with 150 μL phosphate buffered saline
(PBS) (pH = 7.2 - 7.6) and plate-centrifugation, to remove
any residual extract color that may interfere with the
colorimetric assay. The extract-free cells were finally
suspended in 100 μL media with 10% heat inactivated
FBS, and assayed for viability using the colorimetric
MTT based in vitro toxicology assay kit following the
manufacturer instructions. The assay measures the amount
of the blue-colored formazan accumulated intracellularly
following cleavage of the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) reagent by
mitochondrial dehydrogenases of the viable cells. The
absorbance of the produced intracellular formazan which is
proportional to the number of viable cells present was de-
termined at 550 nm. Absorbance for background correc-
tion was determined at 620 nm. Absorbance of wells filled
with media alone was used as a blank and untreated control
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tracts. The percentage of cell survival was calculated after
background absorbance correction and blank absorbance
subtraction as follows: % Cell viability = 100 Χ Experimental
well absorbance / untreated control well absorbance.Cytotoxicity assay
The THP-1 cells were treated with various extracts or
DMSO concentrations. Cells in the positive control wells
were treated with 1% Triton X-100 solution, and negative
control wells cells were incubated in culture media alone.
Blank wells contained the corresponding extract concentra-
tions or Triton X-100 solution or media without cells. The
lactate dehydrogenase (LDH) based in vitro toxicology
assay kit was used to assay for cytotoxicity following the
manufacturer instructions. The assay measures membrane
integrity as a function of the amount of cytoplasmic LDH
released into the medium. LDH reduces NAD into NADH,
which is utilized in the reduction of a tetrazolium dye to
colored formazan. The amount of formazan which isFigure 1 Reduction of THP-1 cells and PBMCs viability in response to
curves of THP-1 cells (A) and PBMCs (B) were constructed after 48 h treatm
viability was assayed by the colorimetric MTT based assay. The X-axis is in lproportional to the amount of LDH release from dead cells
was measured colorimetrically at 450 nm. Absorbance for
background correction was determined at 620 nm.
The percentage of cell viability was calculated as
follows: % Cell viability = 100 –% cell cytotoxicity. The %
cell cytotoxicity = 100 X (experimental well absorbance –
negative control well absorbance) / (positive control well
absorbance –negative control well absorbance). All
calculations were performed after background absorbance
correction and blank absorbance subtraction.Statistical analysis
All experiments were performed in triplicates and each
experiment was performed for two times. The results
were expressed as a mean viability percentage ± standard
deviation (SD). Dose response curves were prepared with
Microsoft Office Excel 2007 software.
The data were analyzed using the GraphPad Prism
software (Version. 6). The log (inhibitor) vs. response
curve equation was used to determine the best fit and toincreasing extracts and DMSO concentrations. Dose response
ent with O. syriacum and T. vulgaris extracts and DMSO. The cells
ogarithmic scale.
Table 1 IC50 values and selectivity indices (SI) of







O. syriacum 2.126 (1.934 - 2.339) 0.425 (0.339 - 0.533) < 0.0001 0.2
T. vulgaris 0.157 (0.133 - 0.186) 0.334 (0.311 - 0.359) < 0.0001 2.1
All values were determined by GraphPad Prism nonlinear regression analysis.
The Log (inhibitor) vs. response - Variable slope (four parameters) equation
was used for best fit of all extracts curves. In all of these curves, the bottom
was constrained to zero value. SI = IC50 of extract in the normal cell line/IC50
of the same extract in cancer cell line.
Ayesh et al. BMC Research Notes 2014, 7:612 Page 4 of 6
http://www.biomedcentral.com/1756-0500/7/612determine the IC50 and LC50 values, the concentration
that provokes a response half way between the maximal
and the maximally inhibited cell viability. The obtained
curves on leukemic and normal cells for each extract
were compared with respect to their IC50/LC50 and slope
and the P-value was determined with 95% confidence
intervals. Two-regression curves comparison was per-
formed by the F-test and a significant difference was
obtained at P-values < 0.05.Results
Effects of the extracts on THP-1 Cells and PBMCs viability
Both extracts O. syriacum, and T. vulgaris significantly
reduced the number of viable THP-1 cells and PBMCs
in a concentration dependent manner [Figure 1]. No effect
was obtained with DMSO at the effective T. vulgaris
extract concentrations. T. vulgaris extract effect was
selective against leukemic cells with selectivity index (SI)
of 2.1. An SI value <2 indicates a general nonspecific
toxicity. On the other hand, the O. syriacum extract effect
was more potent on normal cells than on leukemic cells.Figure 2 Cytotoxic effect on THP-1 cells in response to increasing ext
were constructed after 48 h treatment with O. syriacum and T. vulgaris extr
X-axis is in logarithmic scale.The IC50 values for THP-1 cells and PBMCs as well as
selectivity indices are listed in Table 1.Cytotoxic effects of the extracts on THP-1 cells
The LDH assay was used in order to determine if the
reduction in cell viability obtained with MTT assay
was due to cytotoxicity or to an antiproliferative
effect. T. vulgaris extract has not shown any cytotoxic
effect against THP-1 leukemic cells compared to DMSO
(P-value = 0.6520) [Figure 2]. O. syriacum extract on the
other hand has shown significant cytotoxic effect against
THP-1 cells with LC50 value of 9.646 mg/mL.Discussion
In this study, T. vulgaris exhibited a selective dose
dependent inhibition of THP-1 proliferation (cytostatic
activity) at the applied concentrations and exposure time
rather than killing them (cytotoxic activity). These promis-
ing findings give hope that T. vulgaris may contain cancer
therapeutic agents that, once purified, are more selective
to leukemic cells than normal blood cells at relatively low
concentrations. Furthermore, T. vulgaris is among the
safest extracts used in herbal medicine, exhibiting only
minor adverse effects [16].
Our results are consistent with other studies which
demonstrated a dose dependent proliferation inhibition
of human cancer cell lines from breast cancer, leukemia,
cervical epithelial carcinoma, oral cavity squamous cell
carcinoma, lung carcinoma and prostate carcinoma
[11,13,14,17]. T. vulgaris essential oil were previously
shown to interfere with the transcription of genes
involved in the cell cycle, cell death and cancer, namely,
interferon signaling, N-glycan biosynthesis and extracellular
signal-regulated kinase 5 (ERK5) signaling [13].racts and DMSO concentrations. Dose response curves of THP-1 cells
acts and DMSO. Cytotoxicity was determined by LDH based assay. The
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both reduced viability and increased cytotoxicity of the
THP-1 and PBMCs. This would have been a much more
valuable finding if the effect of O. syriacum extract was
selective against the leukemic cells.
To the best of our knowledge, no previous studies
have assessed the effect of O. syriacum against leukemia,
although few ones reported an antiproliferative effect of
O. syriacum crude extract against cancer cell lines de-
rived from breast adenocarcinoma and human cervical
adenocarcinoma [3,4].
The effects imposed by the plant extracts on the
normal PBMCs may have been aided by the challenges
they face in culture, particularly when the culture media
composition is modified by many substances present in
the crude extracts. Such challenges are expected to affect
normal cells more than leukemic cancer cells, which have
gained some growth advantages during their multistage
progress toward cancer. In this regard, T. vulgaris was
shown by others to be inhibitory on normal Vero cell line
and PBMCs at high concentrations [12,17]. Only one
study was found in the literature to deal with O. syriacum
cytotoxicity against the, supposed, normal diploid human
embryonic fibroblasts MRC-5 cell line [18]. Like our
results, the study showed that methanolic extracts of
O. syriacum were cytotoxic against the MRC-5 cells
with IC50 > 64 μg/mL. No other studies were found in
the literature to investigate the cytotoxicity of the O.
syriacum extracts against PBMCs.
T. vulgaris and O. syriacum essential oils cytotoxicity
was investigated by others in vivo in Wistar rats, and no
significant variations of hematological or biochemical
parameters were noticed after the oral treatment with
these essential oils compared to the control group treated
with physiological solution [19].
Conclusion
In conclusion, T. vulgaris and O. syriacum are both anti-
leukemic in vitro. T. vulgaris represents a potential
selective cytostatic and safe target for future anticancer
agents’ development. O. syriacum, on the other hand, is
cytotoxic against the leukemia cell line THP-1. Further
in vitro and in vivo research has to be performed on the
molecular mechanisms of their action as well as on the
chemical identity of their active substances.
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